Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- GTX128428 - Provider product page
- Provider
- GeneTex
- Product name
- Carbonic Anhydrase IX antibody
- Antibody type
- Polyclonal
- Reactivity
- Human, Mouse
- Host
- Rabbit
Submitted references 3'UTR polymorphisms of carbonic anhydrase IX determine the miR-34a targeting efficiency and prognosis of hepatocellular carcinoma.
5T4-specific chimeric antigen receptor modification promotes the immune efficacy of cytokine-induced killer cells against nasopharyngeal carcinoma stem cell-like cells.
Rhapontigenin inhibits TGF-β-mediated epithelial‑mesenchymal transition via the PI3K/AKT/mTOR pathway and is not associated with HIF-1α degradation.
Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.
Hua KT, Liu YF, Hsu CL, Cheng TY, Yang CY, Chang JS, Lee WJ, Hsiao M, Juan HF, Chien MH, Yang SF
Scientific reports 2017 Jun 30;7(1):4466
Scientific reports 2017 Jun 30;7(1):4466
5T4-specific chimeric antigen receptor modification promotes the immune efficacy of cytokine-induced killer cells against nasopharyngeal carcinoma stem cell-like cells.
Guo X, Zheng H, Luo W, Zhang Q, Liu J, Yao K
Scientific reports 2017 Jul 7;7(1):4859
Scientific reports 2017 Jul 7;7(1):4859
Rhapontigenin inhibits TGF-β-mediated epithelial‑mesenchymal transition via the PI3K/AKT/mTOR pathway and is not associated with HIF-1α degradation.
Yeh YH, Wang SW, Yeh YC, Hsiao HF, Li TK
Oncology reports 2016 May;35(5):2887-95
Oncology reports 2016 May;35(5):2887-95
Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.
Valtorta S, Belloli S, Sanvito F, Masiello V, Di Grigoli G, Monterisi C, Fazio F, Picchio M, Moresco RM
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2013 Jul;54(7):1106-12
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2013 Jul;54(7):1106-12
No comments: Submit comment
Supportive validation
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- Carbonic Anhydrase IX antibody detects Carbonic Anhydrase IX protein by western blot analysis.A. 30 ?g HepG2 whole cell lysate/extract (untreated)B. 30 ?g HepG2 whole cell lysate/extract ( 200 ?M CoCl2 treatment for 24 hr)10% SDS-PAGECarbonic Anhydrase IX antibody (GTX128428) dilution: 1:1000 The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody.
Supportive validation
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- Carbonic Anhydrase IX antibody detects Carbonic Anhydrase IX protein at membrane by immunofluorescent analysis.Sample: 200 £gM CoCl2 treated (right) or untreated (left) A431 cells were fixed in ice-cold MeOH for 5 min.Green: Carbonic Anhydrase IX protein stained by Carbonic Anhydrase IX antibody (GTX128428) diluted at 1:500.Blue: Hoechst 33342 staining.
Supportive validation
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- Carbonic Anhydrase IX antibody detects Carbonic Anhydrase IX protein at membrane on human cervical carcinoma by immunohistochemical analysis. Sample: Paraffin-embedded cervical carcinoma. Carbonic Anhydrase IX antibody (GTX128428) dilution: 1:500.
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- Carbonic Anhydrase IX antibody detects Carbonic Anhydrase IX protein at cell membrane in human renal cell carcinoma by immunohistochemical analysis. Sample: Paraffin-embedded human renal cell carcinoma. Carbonic Anhydrase IX antibody (GTX128428) diluted at 1:500.
